BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32513066)

  • 1. Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients.
    Raihan R; Akbar SMF; Al Mahtab M; Khan MSI; Tabassum S; Tee KK; Mohamed RB
    Viral Immunol; 2020 Sep; 33(7):530-534. PubMed ID: 32513066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.
    Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
    J Infect Dis; 2006 May; 193(9):1258-65. PubMed ID: 16586363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.
    Kao JH; Chen PJ; Lai MY; Chen DS
    Gastroenterology; 2003 Feb; 124(2):327-34. PubMed ID: 12557138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.
    Zheng JX; Zeng Z; Zheng YY; Yin SJ; Zhang DY; Yu YY; Wang F
    J Viral Hepat; 2011 Oct; 18(10):e423-31. PubMed ID: 21914059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
    Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
    J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.
    Tong MJ; Blatt LM; Kao JH; Cheng JT; Corey WG
    Liver Int; 2007 Dec; 27(10):1356-63. PubMed ID: 17900245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.
    Chu CM; Lin CC; Lin SM; Lin DY; Liaw YF
    Dig Dis Sci; 2012 Jan; 57(1):232-8. PubMed ID: 21837473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan.
    Chen CH; Lee CM; Lu SN; Changchien CS; Eng HL; Huang CM; Wang JH; Hung CH; Hu TH
    J Clin Microbiol; 2005 Dec; 43(12):6000-6. PubMed ID: 16333089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the distribution of hepatitis B virus precore and basic core promoter mutations in Guizhou area].
    Ding JJ; Liu YH; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Feb; 28(2):169-72. PubMed ID: 17649690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.
    Lu X; Xu Q; Bu X; Ma X; Zhang F; Deng Q; Zhang Y; Ding J
    Int J Clin Exp Pathol; 2014; 7(9):6048-55. PubMed ID: 25337250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
    Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
    Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh.
    Raihan R; Akbar SMF; Al Mahtab M; Takahashi K; Masumoto J; Tabassum S; Tee KK; Binti Mohamed R
    PLoS One; 2019; 14(6):e0218744. PubMed ID: 31251754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease.
    Takahashi K; Ohta Y; Kanai K; Akahane Y; Iwasa Y; Hino K; Ohno N; Yoshizawa H; Mishiro S
    Arch Virol; 1999; 144(7):1299-308. PubMed ID: 10481738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection.
    Zou Z; Li B; Xu D; Zhang Z; Zhao JM; Zhou G; Sun Y; Huang L; Fu J; Yang Y; Jin L; Zhang W; Zhao J; Sun Y; Xin S; Wang FS
    J Clin Gastroenterol; 2009 Feb; 43(2):182-90. PubMed ID: 18633332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.